Answers are grounded in this paper and cite their sources.
Catalysts improve sulfamethoxazole degradation in wastewater, indicating effective activation via singlet oxygen.
This study investigates the activation mechanism of boron-doped carbon (BMC) catalysts for the degradation of the antibiotic sulfamethoxazole (SMX) via persulfate (PMS) activation. The catalysts were synthesized using a sequential double-melting calcination method, resulting in mesoporous carbon nanosheets characterized by hierarchical macro-mesopores and atomically dispersed dual active sites. Comprehensive characterization was performed using BET, SEM, TEM, FT-IR, XPS, XRD, and Raman techniques. The optimized BMC catalyst demonstrated excellent performance, achieving complete removal of sulfamethoxazole (100%) and a high mineralization rate (~90%) within 45 min. Mechanistic analysis, including electron paramagnetic resonance (EPR), revealed that the degradation predominantly follows a singlet oxygen (1O2)-dominated pathway. The system exhibited broad applicability to various pollutants, along with notable operational stability and robust resistance to common environmental interferents. Persulfate activation was primarily attributed to boron-active sites, while the hierarchical mesoporous structure facilitated both pollutant enrichment and catalytic efficiency.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: